Search

Objective: To evaluate the outcomes of pregnancies with maternal heart disease. Material and Method: The results of 115 patients in our clinic between 2013 and 2018 were retrospectively analyzed. The type of heart disease and functional classification of the New York Heart Association were taken into consideration when evaluating the cases. Results: According to the New York Heart Association classification, the distribution of patients was 67.1% for stage I, 18.2% for stage II, and 14.7% for stage III-IV. There was no maternal or perinatal mortality. The incidence of rheumatic and congenital heart diseases was 51.3% and 27.8%, respectively. Maternal morbidity was observed in 18 cases (15.6%). Mean gestational age and birth weight were significantly higher in the stage I-II functional capacity group (p<0.001). Maternal morbidity and admission rates to neonatal intensive care unit were significantly higher in the stage III-IV functional capacity group (p<0.001). There was no significant difference between stage I-II and stage III-IV groups in terms of cesarean delivery rates and fetal growth restriction (p>0.05). Conclusion: It is possible to obtain satisfactory results for both mother and fetus in the majority of pregnant women with heart disease when managed with a multidisciplinary approach. [ABSTRACT FROM AUTHOR]